SCHEMBL24809672

SCHEMBL24809672

CC(C)(O)CNc1c(NC(=O)CCCCC(F)(F)F)c(Cl)nc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 8/20 0.41
KDM4E B2RXH2 8/20 0.41
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
GLA P06280 4/20 0.37
MAPT P10636 2/20 0.37
RAB9A P51151 2/20 0.37
KCNJ11 Q14654 3/20 0.37
ABCC9 O60706 1/20 0.37
ABCC8 Q09428 1/20 0.37
KCNJ8 Q15842 1/20 0.37
TSHR P16473 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MAPK1 P28482 1/20 0.37
MAOB P27338 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TOP2A P11388 2/20 0.35
TOP2B Q02880 1/20 0.35
BCHE P06276 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24808064 0.97 KDM4E (0.40) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL24808190 0.89 KDM4E (0.52) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL24808465 0.87 KDM4E (0.49) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL6730707 0.83 ACSS2 (0.39) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL7637380 0.79 KDM4E (0.44) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL30583320 0.74 POLB (0.41) GAAKDM4EALDH1A1HPGDMAPT
SCHEMBL21632144 0.72 GAA (0.47) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL22790508 0.72 TLR7 (0.48) GAAKDM4EALDH1A1HPGDRAB9A
SCHEMBL842305 0.71 ATM (0.42) GAAKDM4EALDH1A1HPGDGLA
SCHEMBL8571971 0.71 KDM4E (0.43) GAAKDM4EALDH1A1HPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411421-A1 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF CHOU, YU-CHENG (TW) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411421-A1 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS AND USE THEREOF TLR7, TLR8, TLR6 GAA 3930/4885KDM4E 986/4885ALDH1A1 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.